The Copa Committee has revealed that Rs. 6,259 million worth of drugs have been substandard in the last nine years due to improper storage and about ninety nine percent of such substandard drugs have been given to patients.
Accordingly, it is revealed that from 2011 to 2020, Rs. 6,259 million worth of drugs have failed.
In this situation, it has not been possible to recover the cost of quality failed drugs from the suppliers.
The Committee on Public Accounts has directed the Ministry of Health, Nutrition and Indigenous Medicine to complete the process of facilitating the storage of medicines to ensure safety.
The committee also observed that the temperature in the warehouses owned by the Medical Supplies Division was not maintained properly and that drugs were stored in the corridors of the central drug warehouses and hospitals.
Meanwhile, the Secretary to the Ministry has pointed out that if there is a system to identify the failure of the condition as soon as the drugs are received, the loss can be recovered from the suppliers' guarantee.
The Committee has directed the Secretary to the Ministry that the Medical Supplies Division should take action to recover the quality of medicines or medical supplies from the relevant suppliers instead of recovering them from the State Pharmaceutical Corporation.
These facts were contained in the first report of the second session of the Ninth Parliament of the Copa Committee, which was tabled in Parliament recently (May 20) by the Chairman of the Committee on Public Accounts, Prof. Tissa Vitarana.
This report contains information on the investigations of 7 government agencies and one special audit report convened by the Committee on Public Accounts during the period 20.08.08.09 to 2021.11.19.
No comments:
Post a Comment